7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 
      
    		                                    
      cash flow from operating activities:
    		                                    
      net income from consolidated operations
    		-6,826,000 -19,256,000 -11,899,000 -6,190,000 -14,694,000 -9,090,000 -13,846,000 -134,334,000 -13,466,000 -11,590,000 -15,849,000 -24,076,000 1,343,000 11,099,000 153,557,000 103,677,000 122,224,000                    
      adjustments to reconcile net income to net cash from operating activities:
    		                                    
      equity-based compensation
    		9,717,000 10,039,000 10,550,000 10,408,000 10,920,000 11,635,000 11,518,000 11,432,000 10,902,000 10,323,000 10,265,000 10,022,000 8,972,000 8,030,000 5,616,000 5,020,000 4,374,000 3,526,000 2,962,000 3,003,000 3,150,000 1,080,000 924,000 938,000 951,000 737,000 583,000 598,000 588,000 573,000 545,000 581,000 549,000 424,000 565,000 535,000 
      depreciation and amortization
    		6,038,000 6,054,000 5,919,000 6,192,000 5,920,000 6,153,000 6,663,000 6,533,000 6,419,000 6,312,000 6,879,000 9,802,000 9,820,000 8,345,000 4,695,000 3,491,000 3,173,000              516,000 473,000 438,000 405,000 412,000 420,000 
      adjustment for credit losses
    		1,128,000 2,591,000 2,075,000  947,000                                
      noncash lease expense
    		485,000 362,000 350,000 477,000 604,000 1,169,000 1,510,000 1,517,000 1,627,000 1,707,000 1,561,000 1,602,000 1,601,000 1,233,000 477,000 472,000 384,000 216,000 82,000 64,000 125,000 112,000 108,000 107,000 105,000 101,000 100,000          
      (gain) loss on disposal of fixed asset
    		-1,000 0 -2,000        -179,000                          
      amortization of discount of marketable securities
    		-1,097,000 -1,406,000 -1,658,000  -1,335,000 -1,486,000 -1,184,000                              
      deferred taxes
    		-864,000 -113,000 -133,000 -364,000 -2,358,000 -457,000 -557,000 502,000 19,382,000 -3,218,000 -5,200,000 -3,346,000 2,705,000 -2,142,000 -5,497,000 -1,614,000 -3,519,000 -2,269,000 -786,000 -692,000    0     -352,000 -101,000 -434,000      
      unrecognized tax benefits
    		163,000 137,000 137,000 -1,762,000 31,000   -3,577,000    8,010,000 96,000 520,000 485,000 191,000 29,000 32,000 96,000 -12,000                 
      net realized (gain) loss on marketable securities
    		                                    
      impairment loss
    		0                                    
      other
    		1,000 12,000 21,000 -21,000 19,000 7,000 -12,000 8,000 -49,000   12,000 -6,000 -32,000 15,000 7,000 -14,000 0 -8,000 15,000 -1,000 36,000 -42,000 11,000 3,000 66,000 -28,000 26,000 -20,000 10,000 28,000      
      changes in operating assets and liabilities:
    		                                    
      trade accounts receivable
    		4,907,000 -8,257,000 -4,524,000 -13,325,000 -1,585,000 -2,877,000 1,484,000 -5,208,000 -12,062,000 10,327,000 9,331,000 44,424,000 22,412,000 34,726,000 -32,924,000  32,543,000 67,055,000 -34,595,000                  
      income tax
    		-24,000 -34,793,000 1,761,000                                  
      other current and long-term assets
    		-1,371,000 -458,000 804,000 775,000 -4,673,000 -1,033,000 5,130,000 2,304,000 888,000 -2,135,000 -1,629,000 -8,059,000 5,576,000 -4,816,000 2,962,000 9,890,000 3,939,000 3,084,000 -9,109,000 -1,973,000 -15,349,000 -2,903,000 -924,000 -76,000 267,000 119,000 64,000          
      accounts payable
    		-102,000 386,000 -658,000 -808,000 2,278,000 1,841,000 -245,000 129,000 -2,578,000 -2,592,000 -1,855,000 6,992,000 -22,073,000 -12,368,000 2,110,000 -3,204,000 1,254,000 -4,000,000 -6,256,000 7,942,000 12,391,000 377,000 1,907,000 -238,000 33,000 -203,000 79,000 277,000 1,169,000 -1,562,000 218,000 -377,000 569,000 -122,000 -433,000  
      contract liabilities
    		-363,000 -144,000 582,000 -732,000 223,000            965,000 -7,046,000 -12,616,000                  
      customer deposits
    		939,000 -99,000 83,000 681,000 632,000                                
      accrued liabilities and other liabilities
    		-1,132,000 5,203,000 -7,485,000 628,000 -1,827,000 -2,813,000 51,000 14,531,000 4,195,000 4,596,000 -9,114,000 -18,394,000 -13,169,000 8,495,000 -8,231,000 14,034,000 -4,037,000   10,486,000 21,499,000                
      operating lease liabilities
    		-470,000 -355,000 -354,000 -483,000 -601,000    -1,618,000         -211,000 -82,000 -64,000 -120,000 -104,000 -101,000 -99,000 -122,000 -95,000 -93,000          
      net cash from operating activities
    		11,107,000 -30,171,000 -4,431,000 25,018,000 -15,509,000 4,285,000 7,266,000 14,933,000 10,240,000 9,737,000 -7,907,000 33,207,000 20,776,000 11,126,000 188,411,000 77,086,000 152,201,000 76,111,000 233,179,000  9,415,000 -4,409,000 1,366,000         -1,241,000 500,000 1,365,000 707,000 1,254,000 
      cash flow from investing activities:
    		                                    
      maturities of marketable securities
    		40,235,000 60,230,000 32,445,000 71,787,000 117,935,000 64,623,000 95,450,000 131,668,000 118,043,000 117,439,000 141,408,000 100,821,000 61,281,000 42,672,000 27,760,000 22,326,000 26,978,000 20,080,000 14,458,000 6,800,000 5,792,000 2,401,000 4,926,000 4,750,000 8,100,000 7,900,000 3,600,000 8,609,000 7,704,000 5,806,000 5,850,000 5,785,000 1,800,000 2,600,000 1,000,000  
      proceeds from sale of marketable securities
    		   2,742,000 25,929,000 18,696,000 56,903,000     6,769,000 0 0 133,407,000 29,940,000 104,113,000   9,023,000                 
      proceeds from sale of fixed assets
    		3,000 0 2,000 0 38,000 17,000 258,000 335,000 22,000 220,000 198,000 172,000 222,000 4,000 14,000 41,000 9,000 0 13,000                  
      purchase of marketable securities
    		   -98,206,000 -115,380,000 -63,088,000 -195,741,000 -148,313,000 -93,064,000 -106,611,000 -143,926,000 -160,715,000 -11,779,000 -115,355,000 -130,133,000 -186,551,000 -99,132,000 -205,337,000 -219,470,000 -310,796,000 -1,176,000 -4,395,000 -7,992,000 -40,231,000 -1,668,000 -4,190,000 -5,988,000 -11,022,000 -1,695,000 -6,787,000 -4,683,000 -6,407,000 -1,670,000 -802,000 -2,780,000  
      purchases of fixed assets
    		-6,050,000 -6,826,000 -4,718,000 -3,778,000 -19,537,000 -12,944,000 -4,056,000 -3,106,000 -4,923,000 -12,144,000 -2,034,000 -4,722,000 -5,435,000 -3,258,000 -5,360,000 -5,983,000 -3,402,000 -2,935,000 -11,492,000 -23,794,000 -10,129,000 -411,000 -796,000 -461,000 -88,000 -499,000 -134,000 -123,000 -1,047,000 -36,000 -1,116,000 -1,141,000 -237,000 -1,427,000 -90,000 -409,000 
      acquisition of businesses, net of cash
    		                                    
      net cash from investing activities
    		19,084,000 53,404,000 27,729,000 -27,455,000 8,985,000 7,304,000 -47,186,000 24,270,000 20,078,000 -1,096,000 -4,354,000 -92,599,000 44,289,000 -213,692,000 688,000 -140,259,000 -34,793,000 -155,005,000 -216,491,000 -318,767,000 -1,404,000 -2,405,000 -3,862,000 -36,079,000 6,344,000 3,211,000 -2,522,000 -2,536,000 4,962,000 -1,527,000 51,000 -1,763,000 -2,568,000 4,152,000 -1,870,000 -39,416,000 
      cash flow from financing activities:
    		                                    
      repurchase of common stock
    		0 -2,205,000 -8,679,000 0 0 0 -225,000 -22,862,000    -29,058,000 -34,702,000                        
      common stock withholding for employee tax obligations
    		-357,000 -345,000 -1,887,000 -242,000 -431,000 -544,000 -1,682,000 -1,114,000 -517,000 -232,000 -869,000 -316,000 -522,000 -436,000 -494,000 -688,000 -2,915,000                    
      repayment of notes payable
    		0 -1,000 -470,000 0 -1,000 -464,000 -765,000 -1,837,000 -1,630,000   0 1,000 7,000 -375,000                      
      principal paid for finance lease
    		-88,000 -87,000 -136,000 -136,000 -135,000 -138,000 -135,000  -129,000 -231,000 -232,000  -239,000 -149,000 -81,000 -4,000                     
      net cash from financing activities
    		-445,000 -2,638,000 -11,172,000 -327,000 -567,000 -1,146,000 -2,807,000 -25,951,000 -4,474,000 -16,259,000 -1,101,000 -29,593,000 -35,462,000 -11,152,000 -934,000 13,154,000 -2,989,000 27,893,000 47,347,000 218,903,000 42,571,000 -59,000 -164,000 27,639,000 1,127,000 5,000 4,000 5,000 1,000 7,000 2,000 4,000 4,000   37,854,000 
      effect of exchange rate changes on cash and cash equivalents
    		15,000 4,000 11,000 -134,000 157,000 -9,000 -69,000 145,000 -116,000 -206,000 28,000 -279,000 387,000 -571,000 10,000 36,000 -3,000   3,000 18,000 2,000 -3,000 -1,000 -17,000 -14,000 15,000 0 -23,000 -43,000 22,000 12,000     
      net increase in cash, cash equivalents, and restricted cash
    		29,761,000 20,599,000 12,137,000 -2,898,000                                 
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 55,279,000 0                                 
      cash, cash equivalents, and restricted cash at end of period
    		29,761,000 20,599,000 67,416,000 -2,898,000                                 
      supplemental disclosures of cash flow information:
    		                                    
      cash and cash equivalents
    		29,761,000 20,599,000 67,281,000 -2,898,000                                 
      restricted cash
    		0 0 135,000 0                                 
      total cash, cash equivalents, and restricted cash
    		29,761,000 20,599,000 67,416,000 -2,898,000                                 
      income taxes paid
    		133,000 32,749,000 54,000 946,000 24,739,000 596,000 1,307,000 563,000 62,000 956,000 1,680,000 12,000 1,199,000 54,547,000 435,000 67,529,000 49,560,000 119,947,000 33,000 20,584,000 0   0 0   0 0   0 1,000    
      interest paid
    		4,000 -17,000 61,000 50,000 10,000    21,000                            
      supplemental disclosures of non-cash investing and financing activities:
    		                                    
      contingent consideration for business acquisition included in additional paid-in capital
    		                                    
      purchases of fixed assets in accounts payable
    		-510,000 259,000 2,322,000 -682,000 -2,295,000 44,000 4,739,000 511,000 -2,437,000 1,188,000 2,537,000 1,299,000 -468,000 104,000 2,054,000 -1,204,000 1,537,000 -59,000 801,000 580,000 2,325,000   -323,000             
      holdback for acquisition of business included in other long-term liabilities
    		                                    
      operating lease right-of-use assets obtained in exchange for lease liabilities
    		0   0 12,000   0 0   0    91,000 941,000 397,000 368,000 9,000 0   0             
      operating lease right-of-use assets reduced due to lease modification and termination
    		0   0 0                                
      operating lease liabilities removed due to purchasing underlying assets
    		   0                                 
      net realized loss on marketable securities
    		   52,000 71,000 291,000 580,000                              
      sale of fixed assets in other receivable
    		      11,000                              
      cash flow from operating activities
    		                                    
      goodwill impairment loss
    		                                    
      (adjustment) benefit from credit losses
    		                                    
      loss on disposal of fixed asset
    		   103,000 45,000   -124,000 418,000   202,000 -9,000 59,000 250,000 71,000 181,000 375,000 223,000 320,000    0 0    33,000 4,000 51,000  0    
      amortization of (discount) premium of marketable securities
    		        -1,190,000 -714,000 -478,000                          
      impairment of available-for-sale debt securities
    		   0                                 
      cash flow from investing activities
    		                                    
      purchase of preferred stock of privately held company
    		           0                         
      contingent consideration payout related to a business acquisition
    		           0 0 0 -10,000,000                      
      acquisition of businesses, net of cash acquired
    		           -34,924,000 0   0 -43,359,000                    
      cash flow from financing activities
    		                                    
      repayment of investment margin loan
    		        0                            
      proceeds from exercise of stock options
    		       0 0   12,000 0 3,000 16,000 1,000 17,000 24,000 44,000 2,000 62,000 28,000 12,000 12,000 17,000 5,000 4,000 5,000 1,000 7,000 2,000 4,000 4,000    
      supplemental disclosures of cash flow information
    		                                    
      supplemental disclosures of non-cash investing and financing activities
    		                                    
      stock consideration in a business combination
    		                                    
      maturities of marketable securities in ither current assets
    		                                    
      purchases of fixed assets in notes payable
    		           0 0 0 3,833,000                      
      finance lease right-of-use assets obtained in exchange for lease liabilities
    		           0                         
      finance lease right-of-use assets reduced due to lease modification and termination
    		        0                            
      prepaid income tax
    		                                    
      net decrease in cash and cash equivalents
    		     10,434,000 -42,796,000                -2,663,000              
      cash and cash equivalents at beginning of period
    		     0 97,473,000 0 0 0 79,506,000 0 0 0 164,894,000 0 0 0 87,426,000 0 0 0 11,965,000              
      cash and cash equivalents at end of period
    		     10,434,000 54,677,000 13,397,000 25,728,000 -7,824,000 66,172,000 -89,264,000 29,990,000 -214,289,000 353,069,000 -49,983,000 114,416,000 -51,000,000 151,461,000 34,395,000 50,600,000 -6,871,000 9,302,000              
      gain for credit losses
    		      -2,497,000                              
      gain on disposal of fixed asset
    		      183,000                              
      operating and finance lease liabilities
    		      -1,512,000    -1,526,000 -1,500,000 -1,652,000 -1,202,000 -477,000 -474,000                     
      cash paid for interest
    		      439,000                              
      purchases of marketable securities in other current liabilities
    		          3,519,000                          
      operating lease right-of-use assets reduced due to lease termination
    		      57,000                              
      provision (gain) for credit losses
    		                                    
      amortization (discount) of premium of marketable securities
    		                                    
      net income on marketable securities
    		           66,000 9,000 104,000 513,000 591,000                     
      gain in equity-method investments
    		                                    
      income tax payable
    		           -427,000 -2,378,000 -49,398,000 51,376,000 -17,088,000 -8,524,000 -94,123,000 67,203,000 38,692,000 14,627,000 -58,000 34,000 -36,000             
      purchases of intangible assets
    		                                    
      purchase of redeemable preferred stock
    		               0                     
      proceeds from public offerings of common stock, net of issuance costs
    		               13,849,000    203,898,000    27,648,000             
      proceeds from noncontrolling interest
    		               0 0                    
      principal paid for finance leases
    		                                    
      re-payment for the margin account
    		                                    
      net increase in cash and cash equivalents
    		       13,397,000   -13,334,000 -89,264,000 29,990,000 -214,289,000 188,175,000 -49,983,000 114,416,000 -51,000,000 64,035,000 34,395,000 50,600,000                
      maturities of marketable securities in other current assets
    		                                    
      operating lease right-of-use assets reduced due to lease modification or termination
    		                                    
      finance lease right-of-use assets reduced due to lease modification or termination
    		                                    
      contingent consideration for business acquisition included in current liabilities
    		                                    
      public offerings costs included in accounts payable
    		                 -20,000 50,000 -15,000 372,000 1,000 1,000 -2,000             
      allowance for credit losses at beginning of year
    		                                    
      impact of asu 2016-13 adoption
    		                                    
      current period (gain) provision
    		                                    
      write-downs
    		                                    
      allowance for credit losses at end of year
    		                                    
      benefit from credit losses
    		        -2,347,000 -1,871,000 -113,000 7,340,000 6,522,000 7,160,000 11,574,000 4,824,000 848,000 2,195,000 1,064,000                  
      investment in private equity securities
    		             0 -15,000,000                      
      purchase of marketable securities in other current liabilities
    		                      500,000              
      amortization of premium of marketable securities
    		           537,000 1,007,000 1,313,000 1,910,000 2,106,000 2,319,000 1,868,000 1,303,000 530,000 109,000 113,000 105,000 54,000 8,000 7,000 37,000 58,000 79,000 78,000 82,000 84,000 90,000 101,000 95,000  
      equity loss in investee
    		                   -143,000 189,000 193,000 249,000 174,000 175,000 149,000 279,000 234,000 210,000 246,000 245,000 247,000     
      (gain) loss in equity-method investments
    		                                    
      investment in equity-method investees
    		                                    
      borrowing under margin account
    		                 29,000 29,000                  
      public offerings proceeds in other receivable included in other current assets
    		                                    
      current period provision
    		                                    
      gain on equity method investment
    		                                    
      contingent consideration for business acquisition included in other current liabilities
    		                                    
      accounts receivable
    		                   -93,923,000 -77,120,000 -7,541,000 104,000 -1,427,000 220,000 -1,046,000 1,414,000 23,000 -1,003,000 -277,000 -713,000 -545,000 581,000 415,000 -237,000  
      gain on equity-method investments
    		                                    
      customer deposit
    		                -3,817,000 27,903,000 16,816,000                  
      public offerings proceeds included in other current assets
    		                                    
      testing services by payor
    		                                    
      insurance
    		                                    
      institutional
    		                                    
      patient
    		                                    
      total revenue
    		                                    
      adjustments to reconcile net income to net cash provided (used in) by operating activities:
    		                                    
      holding loss on equity securities
    		                 15,000 345,000                  
      proceeds from (payment for) public offerings of common stock, net of issuance costs
    		                 27,869,000 47,787,000                  
      operating lease right-of-use assets reduced due to lease modification
    		                 0 185,000                  
      net income
    		                  200,691,000 166,307,000 46,638,000 3,321,000 -1,956,000 -296,000 1,462,000 331,000 -1,908,000 -2,053,000 -595,000 -1,049,000 -1,910,000 -1,624,000 -1,093,000 -25,000 232,000 813,000 
      depreciation
    		                  1,922,000 1,122,000 722,000 549,000 569,000 558,000 503,000 511,000 535,000 538,000 547,000        
      other current liabilities
    		                  3,924,000                  
      repurchases of capital stock
    		                  -513,000 -16,000 0 0 -46,000              
      benefit from bad debt
    		                   729,000 306,000 14,000 121,000 152,000    79,000 0 182,000 48,000 149,000    103,000 
      impairment loss in equity method investments
    		                                    
      net cash from operations
    		                       -116,000 3,903,000 675,000 1,055,000  -105,000 -57,000 -1,291,000      
      purchase of equipment contributed to equity-method investee
    		                                    
      investment in equity method investee
    		                   0                 
      operating lease liabilities removed due to purchasing of underlying assets
    		                                    
      impairment loss in equity method investment
    		                                    
      proceeds from disposal of fixed assets
    		                                    
      purchase of equipment contributed to equity method investee
    		                           0 0   0     
      payment of public offering costs
    		                     -87,000 -130,000              
      accrued liabilities and other current liabilities
    		                      268,000              
      fixed assets included in accounts payable
    		                      43,000   -40,000 45,000 12,000 -938,000 1,005,000 6,000 115,000 -44,000 932,000 11,000 1,076,000 
      accrued liabilities
    		                        222,000 -13,000 -7,000 199,000 -954,000 1,130,000 158,000 115,000 -95,000 768,000 310,000  
      net increase in cash
    		                               -2,988,000 -1,995,000 4,739,000 -1,163,000 -308,000 
      cash balance at beginning of period
    		                        0 0 6,736,000 0 0 0 6,490,000 0 0 0 7,897,000 0 
      cash balance at end of period
    		                        11,357,000 3,877,000 5,288,000 -1,753,000 4,835,000 -1,620,000 5,274,000 -2,988,000 -1,995,000 4,739,000 6,734,000 -308,000 
      net decrease in cash
    		                         3,877,000 -1,448,000  4,835,000 -1,620,000 -1,216,000      
      deferred income taxes
    		                                   -171,000 
      other current assets
    		                           -124,000 193,000 147,000 -125,000 9,000 -721,000 -482,000 -343,000  
      taxes payable
    		                               0 -1,000 -288,000 165,000  
      cash from operating activities
    		                                    
      sale of marketable securities
    		                               0 0    
      payment of initial public offering costs
    		                               0 0    
      income from discontinued operations
    		                                   0 
      income from continuing operations
    		                               -1,624,000 -1,093,000 -25,000 232,000 813,000 
      fair value adjustment recorded upon issuance of class d-2 preferred units
    		                                    
      cash from continuing operations
    		                               -1,241,000 500,000 1,365,000 707,000 1,254,000 
      cash from discontinued operations
    		                                   0 
      proceeds from issuance of common stock, net of offering costs
    		                                    
      cash distributed in split-off of pharma business
    		                                   0 
      distribution to class d-1 preferred unitholder
    		                                    
      proceeds from issuance of class d-2 preferred units
    		                                    
      repurchase and retirement of class d-1 preferred and class d common units
    		                                   -1,000 
      tax distribution to class d common and preferred unitholders
    		                                    
      initial public offering costs included in accounts payable and accrued expenses
    		                                    
      return of capital contribution
    		                                    
      issuance costs of class d-2 preferred units
    		                                    
      tax distribution to class d common and preferred unitholders in other current liabilities
    		                                    
      deferred initial public offering costs included in accounts payable
    		                                    
      equity in net income of affiliate
    		                                    
      operating expenses:
    		                                    
      research and development
    		                                    
      general and administrative
    		                                    
      total operating expenses
    		                                    
      operating income
    		                                    
      other income
    		                                    
      income
    		                                    
      income allocated to class p common units - profit interests
    		                                    
      income allocated to class p common units
    		                                    
      income allocated to class p preferred units
    		                                    
      income per class p common units - profit interests, basic and diluted
    		                                    
      income per class p common units, basic and diluted
    		                                    
      income per class p preferred units, basic and diluted
    		                                    
      weighted-average class p common units - profit interests, basic and diluted
    		                                    
      weighted-average class p common units, basic and diluted
    		                                    
      weighted-average class p preferred units, basic and diluted
    		                                    
      excess tax benefits
    		                                  -59,000  
      capital contributions
    		                                    
      supplemental cash flow information:
    		                                    
      weighted-average class p common units - profits interests - outstanding, basic and diluted
    		                                    
      weighted-average class p preferred units outstanding, basic and diluted
    		                                    
      gain on disposal of fixed assets
    		                                    
      amortization of premium on marketable securities
    		                                    
      fair value adjustment recorded upon issuance of d-2 preferred units
    		                                   0 
      income taxes payable
    		                                    
      issuance of class d-2 preferred units, net of issuance costs
    		                                    
      recapitalization
    		                                    
      increase in accounts receivable
    		                                    
      increase in other current assets
    		                                    
      increase in accounts payable
    		                                    
      increase in accrued liabilities
    		                                    
      proceeds from issuance of d-2 units
    		                                    
      interest and other income
    		                                    
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.